Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

about

Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression.

P2860

Q47912566-6DD1081B-0FFA-4EDF-8372-B7932F976B54

P2860

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

Item

http://www.wikidata.org/entity/Q47791142

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

@en

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

@nl

type

Item

label

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

@en

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

@nl

prefLabel

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

@en

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

@nl

P1476

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

@en

P2093

Mark S Freedman

http://www.w3.org/2001/XMLSchema#string

Mohammad Abdoli

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: Results of an international survey

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.

Benign course in multiple sclerosis: a review.

Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system.

Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice.

P2888

s00415-017-8487-y

P304

1068-1075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00415-017-8487-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

264

http://www.w3.org/2001/XMLSchema#string

P50

Arianna Sartori

P577

2017-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28417192

http://www.w3.org/2001/XMLSchema#string

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

about

P2860

P2860

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698